文献速递血栓与止血

老年急性肺栓塞患者的风险评估与管理策略

Risk assessment and management strategies in older patients with acute pulmonary embolism.
PubMed 文献 · J Thromb Haemost · 2024-10-23

该回顾性分析纳入2015至2022年在一家学术医疗中心诊断的242例70岁及以上急性肺栓塞患者,评估Hestia标准筛选家庭治疗及再灌注治疗结局;Hestia标准阴性者均在24小时内出院,家庭治疗患者14天死亡率0%、大出血1.3%,高危患者14天死亡率51%。

要点

  • Hestia标准筛选家庭治疗在老年肺栓塞患者中安全,59例阴性者均24小时内出院。
  • 81例(35%)接受家庭治疗,14天死亡率和复发静脉血栓栓塞症均为0%,大出血1.3%。
  • 高危患者14天死亡率51%,接受再灌注治疗的8例中5例于5天内死亡。

核心结论

  • 在本队列中,使用Hestia标准筛选老年肺栓塞患者进行家庭治疗是安全的。
  • 高危组患者即使接受再灌注治疗,死亡率仍较高。
  • 欧洲心脏病学会风险分层和急性老年患者评分识别出死亡风险较高的患者,提示其在临床决策中可能有用。

研究设计与样本

  • 回顾性分析,纳入2015至2022年在一家学术医疗中心诊断的70岁及以上急性肺栓塞患者,共242例,平均年龄77岁。

主要发现

  • 59例Hestia标准阴性患者均在24小时内出院,共81例(35%)接受家庭治疗。
  • 家庭治疗患者14天死亡率和复发静脉血栓栓塞症均为0%,大出血发生率为1.3%(1例,95%CI:0.11-6.1)。
  • 欧洲心脏病学会风险分层显示低危9例(3.9%)、中危199例(87%)、高危20例(8.8%)。
  • 20例高危患者中5例低血压主要由其他情况(即脓毒症)引起;8例高危患者接受再灌注治疗。
  • 高危患者14天死亡率为51%(95%CI:27-71);接受再灌注治疗的8例中5例在5天内死亡。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Managing older patients with acute pulmonary embolism (PE) is challenging due to their underrepresentation in clinical trials, comorbidities, and increased complication risk. OBJECTIVES: To evaluate risk assessment and management outcomes in older patients with PE focusing on home and reperfusion treatment. METHODS: A retrospective analysis was conducted on patients aged 70 years or older diagnosed with acute PE at an academic medical center (2015-2022). RESULTS: In total, 242 patients with a mean age of 77 years were included. All 59 patients with negative Hestia criteria were discharged ≤24 hours, and in total, 81 patients (35%) received home treatment. Among these 14-day mortality and recurrent venous thromboembolism were 0% and major bleeding occurred in 1.3% (1 patient, 95% CI: 0.11-6.1). European Society of Cardiology risk classification showed 9 low-risk (3.9%), 199 intermediate-risk (87%), and 20 high-risk (8.8) patients with PE. In 5 of the 20 high-risk patients, hypotension was mainly caused by another condition, that is, sepsis. Eight high-risk patients received reperfusion therapy. The 14-day mortality rate was 51% in high-risk patients (95% CI: 27-71); 5 of 8 patients receiving reperfusion treatment died within 5 days. Patients with an Acute Presenting Older Patient score of ≥45% had higher 14-day mortality (28%; 95% CI: 12-46) compared with <45% (3.2%; 95% CI: 0.85-8.3; hazard ratios: 10.2; 95% CI: 2.6-39). CONCLUSION: Selecting for home treatment using Hestia criteria was safe for older patients with PE in our cohort. Mortality in the high-risk group was high also when receiving reperfusion treatment. The European Society of Cardiology risk classification and Acute Presenting Older Patient score identified patients at higher mortality risk, suggesting their potential utility in clinical decision-making.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Luijten D, Abbel D, Cannegieter SC, et al. Risk assessment and management strategies in older patients with acute pulmonary embolism. J Thromb Haemost. 2024. PMID: 39454882. doi:10.1016/j.jtha.2024.10.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。